<DOC>
	<DOCNO>NCT02490891</DOCNO>
	<brief_summary>The aim study measure tumoral angiogenesis modification RGD-K5 PET/CT 2 cycle chemotherapy patient diffuse large B-cell lymphoma large tumoral mass</brief_summary>
	<brief_title>Study Angiogenesis PET/CT Patients With Diffuse Large B Cells Lymphoma</brief_title>
	<detailed_description>After inclusion PET scan FDG tracer specific tracer angiogenesis perform patient diffuse large B cell lymphoma . After two cycle chemotherapy PET scan tracer perform . Overall survival disease free survival monitor 18 month .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma , B-Cell</mesh_term>
	<mesh_term>Lymphoma , Large B-Cell , Diffuse</mesh_term>
	<criteria>Male Female Age ≥ 18 year old OMS ≤ 1 Histological diagnosis diffuse large Bcell lymphoma ever subtype Presence measurable tumor least node mass superior 3 centimeter Stage I IV Inform consent sign Primary cerebral lymphoma Absence fix FDGPET exam Pregnant , child bearing , breast feeding without effective contraception method woman Hypersensitivity RGDK5 Hypersensitivity FDG Poorly control diabètes ( glycemia ≥ 10 millimoles/liter ) Neoplastic disease ( less 2 year progression )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Lymphoma , angiogenesis , PET scan</keyword>
</DOC>